174
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Association of insurance status with survival in patients with cutaneous T-cell lymphoma

, ORCID Icon, , , , ORCID Icon, & show all
Pages 1253-1260 | Received 26 Apr 2018, Accepted 03 Sep 2018, Published online: 16 Oct 2018

References

  • Edelson RL. Outsmarting cutaneous T-cell lymphoma cells by decoding the language they speak: focusing past and present insights on future prospects. Clin Lymphoma Myeloma Leuk. 2010;10:S59–S62.
  • Korgavkar K, Xiong M, Weinstock M. Changing incidence trends of cutaneous T-cell lymphoma. JAMA Dermatol. 2013;149:1295–1299.
  • Trautinger F, Eder J, Assaf C. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017. Eur J Cancer. 2017;77:57–74.
  • Selman LE, Beynon T, Radcliffe E, et al. We're all carrying a burden that we're not sharing: a qualitative study of the impact of cutaneous T-cell lymphoma on the family. Br J Dermatol. 2015;172:1581–1592.
  • Su C, Nguyen KA, Bai HX, et al. Racial disparity in mycosis fungoides: an analysis of 4495 cases from the US National Cancer Database. J Am Acad Dermatol. 2017;77:497–502.e492.
  • Su C, Nguyen KA, Bai HX, et al. Disease site as a determinant of survival outcome in patients with primary cutaneous peripheral T-cell lymphoma, unspecified: an analysis of 4057 cases from the US National Cancer Database. Leukemia Lymphoma. 2018;59:2105–2112.
  • Nguyen KA, Su C, Bai HX, et al. Disease site as a determinant of survival outcome in patients with systemic anaplastic lymphoma kinase positive anaplastic large cell lymphoma with extranodal involvement: an analysis of 1306 cases from the US National Cancer Database. Br J Haematol. 2018;181:196–204.
  • Amini A, Rusthoven CG, Waxweiler TV, et al. Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States. J Am Acad Dermatol. 2016;74:309–316.
  • Halpern MT, Ward EM, Pavluck AL, et al. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008;9:222–231.
  • Walker GV, Grant SR, Guadagnolo BA, et al. Disparities in stage at diagnosis, treatment, and survival in nonelderly adult patients with cancer according to insurance status. Jco. 2014;32:3118–3125.
  • Niu X, Roche LM, Pawlish KS, et al. Cancer survival disparities by health insurance status. Cancer Med. 2013;2:403–411.
  • Dickman PWC, E. Estimating and modeling relative survival. Stata J. 2015;15:186–215.
  • Geskin L, Malone DC. An exploratory cost-effectiveness analysis of systemic treatments for cutaneous T-cell lymphoma. J Dermatolog Treat. 2018;29:522–530.
  • Geskin LJ. Monoclonal antibodies. Dermatol Clin. 2015;33:777–786.
  • Saruta H, Ohata C, Muto I, et al. Hematopoietic stem cell transplantation in advanced cutaneous T-cell lymphoma. J Dermatol. 2017;44:1038–1042.
  • Majhail NS, Mau LW, Denzen EM, et al. Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large national private claims database. Bone Marrow Transplant. 2013;48:294–300.
  • Su C, Nguyen KA, Bai HX, et al. Comparison of chemoradiotherapy with radiotherapy alone for early-stage extranodal natural killer/T-cell lymphoma, nasal type in elderly patients. Leukemia Lymphoma. 2018;59:1406–1412.
  • Su C, Peng C, Agbodza E, et al. Publication trend, resource utilization, and impact of the US National Cancer Database: a systematic review. Medicine. 2018;97:e9823.
  • Fedewa SA, Lerro C, Chase D, et al. Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database. Gynecol Oncol. 2011;122:63–68.
  • Robbins AS, Chen AY, Stewart AK, et al. Insurance status and survival disparities among nonelderly rectal cancer patients in the National Cancer Data Base. Cancer. 2010;116:4178–4186.
  • Robbins AS, Pavluck AL, Fedewa SA, et al. Insurance status, comorbidity level, and survival among colorectal cancer patients age 18 to 64 years in the National Cancer Data Base from 2003 to 2005. Jco. 2009;27:3627–3633.
  • Resneck J, Jr., Pletcher MJ, Lozano N. Medicare, Medicaid, and access to dermatologists: the effect of patient insurance on appointment access and wait times. J Am Acad Dermatol. 2004;50:85–92.
  • Lideikaitė A, Mozūraitienė J, Letautienė S. Analysis of prognostic factors for melanoma patients. Actamedica. 2017;24:25–34.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.